Microsoft Word - Savient press release re OLEdoc - Rheumatoid factor - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2016-07-11 17:00:31 Inborn errors of purine-pyrimidine metabolism Rheumatology Uric acid Pegloticase Savient pharmaceuticals PEGylation Clinical trial Tophus Hyperuricemia Allopurinol Oxandrolone Gout		Microsoft Word - Savient press release re OLEdoc Add to Reading List Source URL: www.mvpharm.com Download Document from Source Website File Size: 31,31 KB Share Document on Facebook

	Microsoft Word - Savient Press Release ACRdoc DocID: 1rrcY - View Document
	Microsoft Word - Savient press release re ACRdoc DocID: 1reUR - View Document
	Microsoft Word - puricase-Phase I-ivpress release.doc DocID: 1qOjy - View Document
	J Am Soc Nephrol 12: 1001–1009, 2001 Diabetes Insipidus in Uricase-Deficient Mice: A Model for Evaluating Therapy with Poly(Ethylene Glycol)-Modified Uricase SUSAN J. KELLY,* MARIELLE DELNOMDEDIEU,‡ MICHAEL I. OLIVE DocID: 1qiQw - View Document
	5.0 ENDOCRINOLOGY 5.1 DIABETES MELLITUS Last Revised: OCT 2014 Last Reviewed: DEC 2014 Changes Include: Dysglycemia is now is a separate section of the waiver guide (ARWGDM Type 1 DocID: 1q5is - View Document